Louisiana Senate Bill SR67

Louisiana 2014 Regular Session

• Introduced: 4/21/14
• Passed: 4/21/14

Caption

Recognizes the week of April 22nd through 20th as The World Primary Immunodeficiency Week.

Impact

The resolution, while not a legislative bill imposing legal requirements, serves to raise public awareness and encourage education surrounding primary immunodeficiency diseases. By declaring a specific week for recognition, it underscores the need for public support in understanding these disorders, discovering potential cures, and ensuring access to necessary treatments. The recognition of this week can potentially lead to increased funding and support for research initiatives, healthcare access, and advocacy for affected individuals.

Summary

Senate Resolution 67 recognizes the week of April 22nd through April 29th, 2014, as The World Primary Immunodeficiency Week. This resolution aims to bring attention to primary immunodeficiency diseases, which are characterized by a malfunctioning immune system due to either intrinsic or genetic defects. The resolution acknowledges the challenges faced by individuals suffering from these disorders, including the necessity of chronic treatment methods such as immune globulin administration and bone marrow transplantation to prevent life-threatening infections.

Sentiment

The sentiment surrounding SR67 is largely positive, promoting a compassionate understanding of those with primary immunodeficiency diseases. By raising awareness, the resolution acts as a proactive measure to highlight the importance of public and governmental support for affected individuals and their families. Advocates believe that such recognition can foster a sense of community and lead to improved health outcomes for those affected.

Contention

Although there is generally support for the intent behind the resolution, some might argue that such campaigns should lead to more concrete actions and funding to address the challenges faced by those with primary immunodeficiency diseases. The focus may shift towards ensuring that the awareness generated translates into tangible benefits like enhanced healthcare policies or funding for research into these diseases.